Why isn’t every patient with cancer offered a clinical trial? Why are my six little pills not available to every metastatic Her2 patient now? These are the questions and issues that have frustrated me for years, and why I have become a patient ‘advocate’ campaigning for greater access to trials for patients.
There are no easy answers to these questions, but here’s my view of what the main barriers are:
Lesley Stephen, Patient Advocate and Make 2nd Counts Trustee